Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives

被引:100
作者
Sabatini, Rosa [1 ]
Cagiano, Raffaele
机构
[1] Univ Bari, Gen Hosp Policlin, Dept Obstet & Gynecol, I-70121 Bari, Italy
[2] Univ Bari, Gen Hosp Policlin, Dept Pharmacol, I-70121 Bari, Italy
关键词
oral contraceptives; vaginal ring; side effects; sexual desire; sexual satisfaction; discontinuation;
D O I
10.1016/j.contraception.2006.03.022
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The objective of this study was to compare cycle control, tolerability and sexual well-being with the use of three hormonal contraceptives. Methods: In this prospective randomized study, the effects of two combined oral contraceptives [20 mu g of ethinylestradiol (EE)/100 mu g of levonorgestrel and 15 mu g of EE/60 mu g of gestodene] were compared with those of the vaginal ring (15 mu g of EE/120 mu g of etonogestrel). One-year data from 280 women were obtained. We investigated the pattern of menstrual cycle and the incidence of weight gain, nausea, headache, breast tenderness, initability, depression and vaginal dryness. Moreover, desire and sexual satisfaction were evaluated. Finally, the cumulative rate of discontinuation in the three groups was estimated. Conclusion: The analysis of adverse events revealed two crucial points for acceptability, compliance and continuation: poor cycle control and disturbance of sexual intercourse due to vaginal dryness and loss of desire. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:220 / 223
页数:4
相关论文
共 13 条
[1]   Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 μg levonorgestrel and 20 μg ethinyl estradiol (Alesse®) [J].
Archer, DF ;
Maheux, R ;
DelConte, A ;
O'Brien, FB .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 181 (05) :S39-S44
[2]   THE ANALYSIS OF VAGINAL BLEEDING PATTERNS INDUCED BY FERTILITY REGULATING METHODS [J].
BELSEY, EM ;
MACHIN, D ;
DARCANGUES, C .
CONTRACEPTION, 1986, 34 (03) :253-260
[3]   Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol [J].
Bjarnadóttir, RI ;
Tuppurainen, M ;
Killick, SR .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 186 (03) :389-395
[4]   International clinical experience with a new low-dose, monophasic oral contraceptive containing levonorgestrel 100 μg and ethinyl estradiol 20 μg [J].
Boerrigter, PJ ;
Ellman, H ;
Dolker, M .
CLINICAL THERAPEUTICS, 1999, 21 (01) :118-127
[5]   Sexual behavior of women taking low-dose oral contraceptive containing 15 μg ethinylestradiol/60 μg gestodene [J].
Caruso, S ;
Agnello, C ;
Intelisano, G ;
Farina, M ;
Di Mari, L ;
Cianci, A .
CONTRACEPTION, 2004, 69 (03) :237-240
[6]  
Chavez A, 1999, Eur J Contracept Reprod Health Care, V4, P75, DOI 10.3109/13625189909064008
[7]   Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials [J].
Coney, P ;
Washenik, K ;
Langley, RGB ;
DiGiovanna, JJ ;
Harrison, DD .
CONTRACEPTION, 2001, 63 (06) :297-302
[8]  
Dei M, 1997, Eur J Contracept Reprod Health Care, V2, P253
[9]   Trends in contraceptive use in the United States: 1982-1995 [J].
Piccinino, LJ ;
Mosher, WD .
FAMILY PLANNING PERSPECTIVES, 1998, 30 (01) :4-+
[10]   Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives:: A randomized trial of 20 μg and 35 μg estrogen preparations [J].
Rosenberg, MJ ;
Meyers, A ;
Roy, V .
CONTRACEPTION, 1999, 60 (06) :321-329